Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients
- 6 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (9), 2353-2366
- https://doi.org/10.1007/s10072-020-04544-w
Abstract
COVID-19 is a pandemic caused by human coronavirus (HCoV) SARS-CoV-2, which originated in Wuhan, China, at the end of 2019 and spread globally during 2020. Due to the difficulty of clinical decision-making during this period, our study group reviewed current literature focusing on the neurological and psychiatric aspects of COVID-19. Despite the knowledge on this newly discovered virus which is constantly evolving, different pieces of evidence reported an association between COVID-19 and neurological symptoms like headache, dizziness, taste and smell disorders and complications involving the nervous system eventually triggered by the pathologic processes elicited by SARS-CoV-2. It seems that younger patients are less prone to develop severe forms of COVID-19. However, neurological signs have been reported in paediatric patients as well, and in some cases, the infection presented neurological sequelae. Furthermore, children with particular neurological diseases or treated with specific drugs (e.g. immune-suppressant therapies) must be carefully monitored during this pandemic. Neurologists should be aware of the main drug–drug interactions and the neurological side effects of COVID-19 treatments. Notably, adverse mental health impact has been reported in patients with SARS-CoV-2, which could be related either to the social strain or to the eventual neurotropic effects of the virus, which in other infections have been proven to promote the onset of psychiatric symptoms. Further, psychiatric population may be more vulnerable to the infection and at higher risk for adverse outcomes.Keywords
This publication has 81 references indexed in Scilit:
- Acute Necrotizing Encephalopathy: An Underrecognized Clinicoradiologic DisorderMediators of Inflammation, 2015
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attemptsJournal of Affective Disorders, 2011
- Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic SymptomsSchizophrenia Bulletin, 2009
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndromeThe American Journal of Emergency Medicine, 2008
- Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin systemAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)The Journal of Pathology, 2004
- Chloroquine and Nonconvulsive Status EpilepticusAnnals of Internal Medicine, 1995
- Aggravation of myasthenia gravis by erythromycinAnnals of Neurology, 1990